ATOSSA THERAPEUTICS, INC. Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31)
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ATOSSA THERAPEUTICS, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for the quarter ending 2015-03-31 was $4.29M.
- ATOSSA THERAPEUTICS, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for the quarter ending 2014-12-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for the quarter ending 2014-09-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2014 was $14.00M, a 13.80% increase from fiscal 2013.
- ATOSSA THERAPEUTICS, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2013 was $12.30M, a 256.22% increase from fiscal 2012.
- ATOSSA THERAPEUTICS, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2012 was $3.45M, a 39.55% decline from fiscal 2011.
- ATOSSA THERAPEUTICS, INC. development stage entities, stock issued, value, issued for cash (deprecated 2015-01-31) for fiscal 2011 was $5.71M, a 5501.75% increase from fiscal 2010.
| Period end | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 3 month | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 12 month |
|---|---|---|
| 2015-03-31 | $4.29M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $14.00M 10-K · filed 2015-03-30 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | |
| 2013-12-31 | $12.30M 10-K · filed 2015-03-30 | |
| 2012-12-31 | $3.45M 10-K · filed 2014-03-27 | |
| 2011-12-31 | $5.71M 10-K · filed 2014-03-27 | |
| 2010-12-31 | $102.00K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |